Anti-TNFSF11/RANKL/CD254 Antibody (Denosumab)
Catalog No.
F1550
Anti-TNFSF11/RANKL/CD254 Antibody (Denosumab)
Featured Products
Denosumab (anti-TNFSF11) is a RANKL inhibitor that is effective in inhibiting giant cell tumor of bone (GCTB). Denosumab eliminates RANK-positive tumor giant cells and reduces the relative content of proliferative, densely cellular tumor stromal cells.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.16 kDa
Dry ice
615258-40-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
AMG-162
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O14788
Human, Mouse, Rat
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFSF11 / RANKL / CD254
Please avoid freeze-thaw cycles.